STE STERIS plc

  1. Stocks
  2. Healthcare
  3. NYSE: STE

Price (delayed)

$231.86

Market cap

$23.19B

P/E Ratio

81.64

Dividend/share

$1.66

EPS

$2.84

Enterprise value

$26.45B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
The company's equity has surged by 79% YoY
The revenue has grown by 27% YoY and by 13% from the previous quarter
STERIS's quick ratio has increased by 30% from the previous quarter but it has decreased by 22% YoY
STE's P/E is 102% above its 5-year quarterly average of 40.4 and 55% above its last 4 quarters average of 52.8
The company's EPS fell by 43% YoY and by 16% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.steris.com/
Peers: SYK TMO IVC OMI

Key stats

What are the main financial stats of STE
Market
Shares outstanding
100.02M
Market cap
$23.19B
Enterprise value
$26.45B
Valuations
Price to earnings (P/E)
81.64
Price to book (P/B)
3.54
Price to sales (P/S)
6.01
EV/EBIT
65.74
EV/EBITDA
36.75
EV/Sales
6.87
Earnings
Revenue
$3.85B
EBIT
$402.35M
EBITDA
$719.87M
Free cash flow
$401.13M
Per share
EPS
$2.84
Free cash flow per share
$4.02
Book value per share
$65.51
Revenue per share
$38.57
TBVPS
$36.74
Balance sheet
Total assets
$11.75B
Total liabilities
$5.21B
Debt
$3.64B
Equity
$6.54B
Working capital
$1.12B
Liquidity
Debt to equity
0.56
Current ratio
2.42
Quick ratio
1.46
Net debt/EBITDA
4.53
Margins
EBITDA margin
18.7%
Gross margin
42.5%
Net margin
6.5%
Operating margin
11%
Efficiency
Return on assets
2.7%
Return on equity
4.8%
Return on invested capital
8.3%
Return on capital employed
3.7%
Return on sales
10.5%
Dividend
Dividend yield
0.72%
DPS
$1.66
Payout ratio
58.5%

STE stock price

How has the STERIS stock price performed over time
Intraday
0.64%
1 week
-4.06%
1 month
-0.29%
1 year
22.87%
YTD
-4.75%
QTD
-4.75%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$3.85B
Gross profit
$1.63B
Operating income
$423.93M
Net income
$251.36M
Gross margin
42.5%
Net margin
6.5%
STERIS's net margin has plunged by 54% YoY and by 23% from the previous quarter
The company's net income fell by 41% YoY and by 13% QoQ
STE's operating margin is down by 40% year-on-year and by 17% since the previous quarter
The revenue has grown by 27% YoY and by 13% from the previous quarter

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
81.64
P/B
3.54
P/S
6.01
EV/EBIT
65.74
EV/EBITDA
36.75
EV/Sales
6.87
STE's P/E is 102% above its 5-year quarterly average of 40.4 and 55% above its last 4 quarters average of 52.8
The company's EPS fell by 43% YoY and by 16% QoQ
The company's equity has surged by 79% YoY
STE's P/B is 11% above its 5-year quarterly average of 3.2
The P/S is 50% above the 5-year quarterly average of 4.0 and 16% above the last 4 quarters average of 5.2
The revenue has grown by 27% YoY and by 13% from the previous quarter

Efficiency

How efficient is STERIS business performance
STERIS's ROA has plunged by 65% YoY and by 27% from the previous quarter
The ROE has plunged by 61% YoY and by 25% from the previous quarter
STERIS's ROIC has plunged by 57% YoY and by 22% from the previous quarter
The company's return on sales fell by 44% YoY and by 17% QoQ

Dividends

What is STE's dividend history
Dividend details
DPS
$1.66
Dividend yield
0.72%
Payout ratio
58.5%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 126% more than the total liabilities
STE's total liabilities has surged by 185% year-on-year but it is down by 6% since the previous quarter
The total assets has soared by 114% YoY but it has contracted by 2.9% from the previous quarter
STERIS's debt is 44% less than its equity
The company's equity has surged by 79% YoY
STE's debt to equity has surged by 75% year-on-year but it is down by 3.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.